Thema
Journal Article
87
Research Support, Non-U.S. Gov't
39
Multicenter Study
20
EC 2.7.10.1
14
Review
14
Receptor, ErbB-2
13
Research Support, N.I.H., Extramural
12
Antineoplastic Agents, Hormonal
11
Breast cancer
11
Metastatic breast cancer
10
Randomized Controlled Trial
10
094ZI81Y45
9
Antineoplastic Agents
9
Clinical Trial, Phase III
9
Tamoxifen
9
COVID-19
7
Receptors, Estrogen
7
breast cancer
7
Biomarkers, Tumor
6
ERBB2 protein, human
6
NY22HMQ4BX
6
SARS-CoV-2
6
exemestane
6
Androstadienes
5
Antibodies, Monoclonal, Humanized
5
Comparative Study
5
HER2-positive breast cancer
5
Lapatinib
5
PALB2
5
Protein Kinase Inhibitors
5
Receptors, Progesterone
5
immunotherapy
5
31YO63LBSN
4
Cancer
4
Fanconi Anemia Complementation Group N Protein
4
Founder mutations, Haplotype
4
Immune Checkpoint Inhibitors
4
Ipilimumab
4
Letter
4
Nivolumab
4
P188ANX8CK
4
Pertuzumab
4
Route of administration
4
Safety
4
Subcutaneous trastuzumab
4
Trastuzumab
4
hypercoagulability
4
thrombin generation
4
08AN7WA2G0
3
Adjuvant drug therapy
3
mehr ...